NaloxegolNaloxegol (INN; PEGylated naloxol; trade names Movantik and Moventig) is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. Read from the Drugbox of the Wikipedia article Naloxegol, revision 1322744851.

Property

Value

Formula

C34H53NO11, 651.79 g/mol

Protein binding

4.2 %

Elimination half-life

8.5 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.